Michael Gelband ExodusPoint Capital Management
Michael Gelband is a co-founder of ExodusPoint Capital Management, a multi-strategy hedge fund launched by veterans of larger alternative platforms. The firm pursues diversified strategies across asset classes with a focus on risk-managed absolute returns. Gelband’s firm is followed as part of the newer generation of multi-strategy complexes.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$353M |
| 2 |
Microsoft
MSFT
|
+$352M |
| 3 |
Apple
AAPL
|
+$256M |
| 4 |
Alibaba
BABA
|
+$189M |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$125M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SCHW
Charles Schwab
SCHW
|
+$82M |
| 2 |
Generac Holdings
GNRC
|
+$33.7M |
| 3 |
Pool Corp
POOL
|
+$32.5M |
| 4 |
Keurig Dr Pepper
KDP
|
+$31M |
| 5 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$25M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.28% |
| 2 | Consumer Discretionary | 10.77% |
| 3 | Healthcare | 5.09% |
| 4 | Industrials | 4.03% |
| 5 | Financials | 3.78% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1976
Broadstone Net Lease
BNL
$4.32B
| – | – |
-76,961
| Closed | -$1.29M |
|
1977
Scotiabank
BNS
$107B
| – | – |
-28,141
| Closed | -$1.17M |
|
1978
BioNTech
BNTX
$29.3B
| – | – |
-10,860
| Closed | -$752K |
|
1979
BP
BP
$115B
| – | – |
-32,457
| Closed | -$567K |
|
1980
Brady Corp
BRC
$4.3B
| – | – |
-17,174
| Closed | -$687K |
|
1981
Brixmor Property Group
BRX
$8.99B
| – | – |
-31,318
| Closed | -$366K |
|
|
BRY
1982
DELISTED
Berry Corp
BRY
| – | – |
-10,588
| Closed | -$34K |
|
|
STEX
1983
Streamex Corp
STEX
$97M
| – | – |
-1,180
| Closed | -$58K |
|
1984
BioXcel Therapeutics
BTAI
$25.2M
| – | – |
-365
| Closed | -$253K |
|
1985
Bit Origin
BTOG
$3.1M
| – | – |
-2
| Closed | -$13K |
|
1986
Peabody Energy
BTU
$3.37B
| – | – |
-12,413
| Closed | -$29K |
|
1987
BorgWarner
BWA
$13.8B
| – | – |
-121,988
| Closed | -$4.16M |
|
1988
Boyd Gaming
BYD
$5.87B
| – | – |
-8,733
| Closed | -$268K |
|
1989
Beyond Meat
BYND
$254M
| – | – |
-504
| Closed | -$2.51M |
|
1990
Citigroup
C
$221B
| – | – |
-75,784
| Closed | -$3.27M |
|
1991
Caleres
CAL
$457M
| – | – |
-10,315
| Closed | -$99K |
|
1992
Avis
CAR
$5.18B
| – | – |
-27,106
| Closed | -$713K |
|
1993
CarGurus
CARG
$3.28B
| – | – |
-25,303
| Closed | -$547K |
|
1994
Commerce Bancshares
CBSH
$8.37B
| – | – |
-11,151
| Closed | -$468K |
|
1995
Cabot Corp
CBT
$4.4B
| – | – |
-7,162
| Closed | -$258K |
|
1996
Chemours
CC
$2.4B
| – | – |
-67,654
| Closed | -$1.42M |
|
1997
Cameco
CCJ
$44.6B
| – | – |
-10,090
| Closed | -$102K |
|
1998
Carnival Corporation Ltd
CCL
$35.2B
| – | – |
-10,702
| Closed | -$162K |
|
1999
Cogent Communications
CCOI
$470M
| – | – |
-8,488
| Closed | -$510K |
|
|
CCRN
2000
DELISTED
Cross Country Healthcare
CCRN
| – | – |
-23,568
| Closed | -$153K |
|
Similar funds
Michael Gelband's Q4 2020 Portfolio in Review
As of Q4 2020, Michael Gelband held 2,600 positions worth $10.3B, up 105% from $5.02B the previous quarter. Its ten largest holdings account for 42% of the portfolio.
Michael Gelband deployed $4.62B of net new capital in Q4 2020, opening 918 new positions and adding to 493 existing holdings. Its largest new stake was State Street SPDR S&P 500 ETF Trust: 352,707 shares worth $132M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 11% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was Charles Schwab, an estimated $82M trimmed.
- Michael Gelband's largest Q4 2020 buy was State Street SPDR S&P 500 ETF Trust: 352,707 shares worth $132M.
- Michael Gelband added most to Amazon in Q4 2020, an estimated $353M increase.
- Michael Gelband's biggest Q4 2020 reduction was Charles Schwab, cutting an estimated $82M.
- Michael Gelband fully exited Eli Lilly in Q4 2020, selling an estimated $21.7M.
- Michael Gelband's ten largest holdings make up 42% of its $10.3B portfolio in Q4 2020.
- Michael Gelband opened 918 new positions and closed 701 in Q4 2020.
- Michael Gelband's portfolio value rose 105% quarter-over-quarter to $10.3B.
Based on ExodusPoint Capital Management's 13F filing for Q4 2020, filed 16 Feb 2021.